Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.
Zhang W; Konopleva M; Shi YX; McQueen T; Harris D; Ling X; Estrov Z; Quintás-Cardama A; Small D; Cortes J; Andreeff M; Journal Of The National Cancer Institute, 2008, vol. 100, issue 3, p 184, ISSN 14602105. ISBN 14602105.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef